Lessons Learned from SYMPLICITY HTN-3 Results for Further Clinical Trials - Sidney Cohen

↳ This is a section part of Moment: CRT 2016 Technology & Innovation - Japan-US Synergies: Optimal Design for Evaluation of Renal Denervation Devices

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$6.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Lessons Learned from SYMPLICITY HTN-3 Results for Further Clinical Trials presented by Sidney Cohen at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$6.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Clinical Trial Investigators
  • Medical Device Professionals

Session Name: Japan-US Synergies: Optimal Design for Evaluation of Renal Denervation Devices

Track: Technology & Innovation

Learning Objectives

  • Updates on regulatory harmonisation and clinical trial design in the US & Japan

Other Components in this Moment

Overview
Lessons Learned from SYMPLICITY HTN-3 Results for Further Clinical Trials - Sidney Cohen
Optimal Design for Evaluation of Renal Denervation Devices: US Academia View - David Kandzari, MD, FSCAI
Optimal Design for Evaluation of Renal Denervation Devices: Japan Academia View - Takafumi Ueno, MD, PhD
Sham Operation and Other Points to Consider for Evaluation of Renal Denervation Devices: Japan Academia View - Koji Ikeda, PhD
Loading Simple Education